This site is intended for healthcare professionals only
Boots’ parent company Walgreens Boots Alliance has ultimately decided not to sell the UK pharmacy chain, following months of speculation as to who could snap up the health and beauty giant.
This concludes the company’s “strategic review” into its UK business, which reportedly saw it tabling multi-billion pound bids from private equity firms and Asda owners, the Issa brothers.
Register to gain full access to C+D and C+D Community content
Already registered?
Already registered?
Due to shortages in coal tar scalp ointment, the DHSC has asked the manufacturer of an equivalent product - Sebco - to provide increased stock levels to support patients during this time.
Pharmacies in Scotland have been asked to ensure they have the “appropriate stock” of naloxone – a medicine used to reverse the effects of an opiate overdose – following an “increase in sudden collapse” due to overdoses.
As the dust settles on the announcement that NHS England (NHSE) is set for the scrapheap, questions on what a 50% headcount cut means for local commissioners remain…
Boots has issued a recall for 120,000 packs of its own brand paracetamol due to “incorrect packaging” and called on customers to return the product for a “full refund”.
Asda has launched the “UK’s first” adult earache service at over 220 of its pharmacies in England to “[reduce] the burden on NHS services”, with same day appointments available and priced at £25.
